RegeneRx Biopharmaceuticals, Inc. (RGRX) .
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 30/100 1/7 개 기준 통과.
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2013 | $-0.01 | $29.48K | $-671K | -2275.8% |
| 2014 | $-0.03 | $0.00 | $-2.75M | - |
| 2015 | $-0.05 | $60.61K | $-5.27M | -8694.6% |
| 2016 | $0.18 | $93.31K | $229.13K | 245.6% |
| 2017 | $0.00 | $56.65K | $286.49K | 505.7% |
| 2018 | $-0.02 | $69.67K | $-1.99M | -2862.2% |
| 2019 | $-0.01 | $76.76K | $-1.4M | -1829% |
| 2020 | $-0.01 | $76.76K | $-1.52M | -1984.1% |
| 2021 | $-0.01 | $76.76K | $-1.6M | -2081.8% |
| 2022 | $-1.00 | $76.76K | $-1.73M | -2249.8% |
